Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: December 5, 2011
Last updated: October 3, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2003
  Primary Completion Date: March 2003 (Final data collection date for primary outcome measure)